CD44 and hepatocellular carcinoma: In both human and murine models of HCC, CD44 signaling on activated HSCs promotes the expansion of MDSCs, which inhibit cytotoxic T lymphocyte (CTL) and natural killer (NK) cell responses, thus reinforcing an immune-suppressive niche [63,64].